ＮＡＮＯ ＭＲＮＡ(株)の貸借残高情報
| 主市場 | 業種 | 証券コード/EDINET | 英名称 |
|---|
| 東証GRT | 医薬品 | 4571/E05728 | NanoCarrier Co., Ltd. |
| 公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
|---|
| 2013/04/19 | 日証協 | 43,149株 | +17.43% | 25,709株 | +83.15% | 28,282株 | -2.42% | 5,340株 | -36.14% |
| 2013/04/12 | 日証協 | 36,745株 | +15.81% | 14,037株 | +69.8% | 28,983株 | +29.16% | 8,362株 | +63.42% |
| 2013/04/05 | 日証協 | 31,730株 | -14.2% | 8,267株 | -36.08% | 22,439株 | -2.85% | 5,117株 | +282.15% |
| 2013/03/29 | 日証協 | 36,980株 | -3.24% | 12,933株 | -37.27% | 23,097株 | -10.5% | 1,339株 | -76.66% |
| 2013/03/22 | 日証協 | 38,219株 | +2.54% | 20,618株 | +36.25% | 25,807株 | +8.91% | 5,737株 | +161.84% |
| 2013/03/15 | 日証協 | 37,273株 | -1.79% | 15,132株 | +26.65% | 23,696株 | -0.95% | 2,191株 | -55.21% |
| 2013/03/08 | 日証協 | 37,953株 | -1.81% | 11,948株 | -4% | 23,923株 | +0.63% | 4,892株 | +145.46% |
| 2013/03/01 | 日証協 | 38,653株 | +17.69% | 12,446株 | -23.9% | 23,773株 | +11.93% | 1,993株 | -59.7% |
| 2013/02/22 | 日証協 | 32,844株 | -2.9% | 16,355株 | +150.92% | 21,240株 | -4.94% | 4,946株 | +10.95% |
| 2013/02/15 | 日証協 | 33,825株 | +1.8% | 6,518株 | -48.48% | 22,343株 | +2.28% | 4,458株 | -2.47% |
| 2013/02/08 | 日証協 | 33,226株 | +22.48% | 12,652株 | -23.43% | 21,845株 | +15.36% | 4,571株 | -42.42% |
| 2013/02/01 | 日証協 | 27,128株 | +57.5% | 16,523株 | +164.54% | 18,937株 | +38.02% | 7,939株 | +193.06% |
| 2013/01/25 | 日証協 | 17,224株 | -0.79% | 6,246株 | +49.43% | 13,720株 | -6.22% | 2,709株 | +266.08% |
| 2013/01/18 | 日証協 | 17,362株 | +2.95% | 4,180株 | -16.22% | 14,630株 | +1.73% | 740株 | +9.31% |
| 2013/01/11 | 日証協 | 16,864株 | +5.27% | 4,989株 | +1219.84% | 14,381株 | +1.94% | 677株 | +941.54% |
| 2013/01/04 | 日証協 | 16,020株 | +2.55% | 378株 | -86.31% | 14,107株 | +0.39% | 65株 | -96.45% |
| 2012/12/28 | 日証協 | 15,622株 | -7.34% | 2,761株 | -0.04% | 14,052株 | -1.56% | 1,829株 | +12.42% |
| 2012/12/21 | 日証協 | 16,859株 | -15.2% | 2,762株 | +21.73% | 14,274株 | -11.6% | 1,627株 | -65.63% |
| 2012/12/14 | 日証協 | 19,882株 | -18.84% | 2,269株 | -67.85% | 16,147株 | -8.56% | 4,734株 | -13.14% |
※株式分割は考慮していませんのでご注意ください。
Page Top